| Heavyweight | Nonheavyweight |
P value‡
| Normal range |
---|
| (n = 41) | (n = 17) |
---|
AST* (U/L) | 28 (24–38) | 24 (20–30) | 0.053 | 10–40 |
ALT* (U/L) | 38 (29–49) | 20 (15–27) | <0.001 | 5–45 |
γ-GTP* (U/L) | 32 (26–44) | 23 (15–26) | <0.001 | <80 |
Total-C (mg/dL) | 179 ± 32 | 179 ± 31 | 0.966 | 120–219 |
HDL-C (mg/dL) | 48 ± 8 | 51 ± 6 | 0.220 | 40–85 |
LDL-C† (mg/dL) | 105 ± 30 | 109 ± 24 | 0.581 | ≦140 |
TG* (mg/dL) | 112 (75–165) | 80 (66–110) | 0.086 | 30–149 |
UA (mg/dL) | 6.9 ± 1.5 | 6.2 ± 1.0 | 0.048 | 3.8–7.0 |
FPG* (mg/dL) | 85 (82–91) | 80 (78–84) | 0.012 | 70–109 |
Insulin* (μIU/mL) | 8.4 (5.7–11.3) | 5.3 (4.4–6.5) | 0.011 | 1.7–10.4 |
HOMA-IR* | 1.72 (1.13–2.52) | 1.02 (0.91–1.36) | 0.008 | <2.50 |
- Data were expressed as mean ± SD or median (inter quartile range). AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP γ-glutamyl transpeptidase, Total-C total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglyceride, UA uric acid, FPG fasting plasma glucose, HOMA-IR homeostasis model assessment insulin resistance, *Log-transformed variables for non-normally distributed variables (AST, ALT, γ-GTP, TG, FPG, insulin, HOMA-IR) were used to analysis. †The low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation. ‡
P value for difference between heavyweight and nonheavyweight groups was assessed by unpaired t test. Significant differences, P < 0.05